seed
Stage
2
Investors
About
Zoundream AG develops AI-based technology that analyzes infant cries along with multimodal data to enable continuous, non-invasive monitoring of infant health and early detection of neurodevelopmental disorders at home.
Explore Zoundream AG's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.